| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 606953 | 62953 | PROPOFOL LIPURO 10 mg/ml EMULSIÓN INYECTABLE Y PARA PERFUSIÓN | PROPOFOL LIPURO 10 mg/ml EMULSIÓN INYECTABLE Y PARA PERFUSIÓN, 10 viales de 50 ml | 10 mg/ml inyectable 50 ml | 45 | 10 | 34 | 10 viales de 50 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62953/62953_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62953/62953_p.pdf | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 307 | B BRAUN MEDICAL S.A. | 2000-04-13 | 1 | 1 | 1 | 2000-04-13 | 2017-11-15 | 1 | 2018-11-07 | View Edit Delete | ||||||||||||
| 600259 | 66871 | OMEPRAZOL SERRACLINICS 40 mg POLVO PARA SOLUCION PARA PERFUSION EFG | OMEPRAZOL SERRACLINICS 40 mg POLVO PARA SOLUCION PARA PERFUSION EFG , 50 viales | 40 mg | 45 | 50 | 34 | 50 viales | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66871/66871_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66871/66871_p.pdf | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 2616 | LABORATORIOS SERRA PAMIES S.A. | 2005-06-06 | 1 | 1 | 1 | 2005-06-06 | 2005-06-06 | 1 | 2011-10-26 | View Edit Delete | ||||||||||||
| 600757 | 68124 | CEFTAZIDIMA LDP TORLAN 1.000 mg polvo y disolvente para solución inyectable EFG | CEFTAZIDIMA LDP TORLAN 1.000 mg polvo y disolvente para solución inyectable EFG , 50 viales + 50 ampollas de disolvente | 1.000 mg | 45 | 50 | 34 | 50 viales + 50 ampollas de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68124/68124_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68124/68124_p.pdf | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 1626 | LDP LABORATORIOS TORLAN S.A. | 2006-10-30 | 1 | 1 | 1 | 2006-10-30 | 2011-02-28 | 1 | 2012-10-18 | View Edit Delete | ||||||||||||
| 603177 | 71057 | CEFTRIAXONA LDP TORLAN 250 MG POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE INTRAVENOSA EFG | CEFTRIAXONA LDP TORLAN 250 MG POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE INTRAVENOSA EFG, 100 viales + 100 ampollas de disolvente | 250 mg | 45 | 100 | 34 | 100 viales + 100 ampollas de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71057/71057_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71057/71057_p.pdf | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 1626 | LDP LABORATORIOS TORLAN S.A. | 2009-06-17 | 1 | 1 | 1 | 2009-06-17 | 2009-06-17 | 0 | 2012-10-23 | View Edit Delete | ||||||||||||
| 606015 | 76308 | MEROPENEM KERN PHARMA 1000 mg POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG | MEROPENEM KERN PHARMA 1000 mg POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG, 10 viales | 1.000 mg | 45 | 10 | 34 | 10 viales | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76308/76308_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76308/76308_p.pdf | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2012-12-14 | 1 | 1 | 1 | 2019-04-08 | 2019-04-08 | 1 | 2013-04-24 | View Edit Delete | ||||||||||||
| 606016 | 76526 | MEROPENEM KERN PHARMA 500 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG | MEROPENEM KERN PHARMA 500 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG, 10 viales | 500 mg | 45 | 10 | 34 | 10 viales | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76526/76526_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76526/76526_p.pdf | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2012-12-14 | 1 | 1 | 1 | 2019-04-08 | 2019-04-08 | 1 | 2013-04-24 | View Edit Delete | ||||||||||||
| 606832 | 81884 | CLARISCAN 0,5 MMOL/ML SOLUCION INYECTABLE EFG | CLARISCAN 0,5 MMOL/ML SOLUCION INYECTABLE EFG, 10 viales de 10 ml | 0,5 mmol/ml inyectable 10 ml | 45 | 10 | 34 | 10 viales de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/81884/81884_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/81884/81884_p.pdf | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 10603 | GE HEALTHCARE BIO-SCIENCES, S.A.U. | 2017-03-17 | 1 | 1 | 1 | 2017-03-18 | 2017-03-17 | 0 | 2024-07-11 | View Edit Delete | ||||||||||||
| 606833 | 81884 | CLARISCAN 0,5 MMOL/ML SOLUCION INYECTABLE EFG | CLARISCAN 0,5 MMOL/ML SOLUCION INYECTABLE EFG, 10 viales de 15 ml | 0,5 mmol/ml inyectable 15 ml | 45 | 10 | 34 | 10 viales de 15 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/81884/81884_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/81884/81884_p.pdf | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 10603 | GE HEALTHCARE BIO-SCIENCES, S.A.U. | 2017-03-17 | 1 | 1 | 1 | 2017-03-18 | 2017-03-17 | 0 | 2024-07-11 | View Edit Delete | ||||||||||||
| 606834 | 81884 | CLARISCAN 0,5 MMOL/ML SOLUCION INYECTABLE EFG | CLARISCAN 0,5 MMOL/ML SOLUCION INYECTABLE EFG, 10 viales de 20 ml | 0,5 mmol/ml inyectable 20 ml | 45 | 10 | 34 | 10 viales de 20 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/81884/81884_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/81884/81884_p.pdf | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 10603 | GE HEALTHCARE BIO-SCIENCES, S.A.U. | 2017-03-17 | 1 | 1 | 1 | 2017-03-18 | 2017-03-17 | 0 | 2024-07-01 | View Edit Delete | ||||||||||||
| 600514 | 67216 | PROPOFOL LIPOVEN FRESENIUS 20 mg/ml EMULSION INYECTABLE Y PARA PERFUSION | PROPOFOL LIPOVEN FRESENIUS 20 mg/ml EMULSION INYECTABLE Y PARA PERFUSION , 10 viales de 50 ml | 20 mg/ml inyectable 50 ml | 45 | 10 | 34 | 10 viales de 50 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67216/67216_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67216/67216_p.pdf | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1097 | FRESENIUS KABI ESPAÑA, S.A.U. | 2005-11-16 | 1 | 1 | 1 | 2005-11-16 | 2006-03-15 | 1 | 2012-01-02 | 652660 | View Edit Delete | |||||||||||
| 603248 | 71574 | CEFTAZIDIMA KABI 1 g POLVO PARA SOLUCION INYECTABLE EFG | CEFTAZIDIMA KABI 1 g POLVO PARA SOLUCION INYECTABLE EFG, 10 viales | 1.000 mg | 45 | 10 | 34 | 10 viales | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71574/71574_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71574/71574_p.pdf | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2009-10-26 | 1 | 1 | 1 | 2009-10-26 | 2009-10-26 | 1 | 2013-03-04 | View Edit Delete | ||||||||||||
| 605455 | 72610 | MEROPENEM KABI 500 mg POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG | MEROPENEM KABI 500 mg POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG, 10 viales de 20 ml | 500 mg | 45 | 10 | 34 | 10 viales de 20 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72610/72610_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72610/72610_p.pdf | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2011-05-27 | 1 | 1 | 1 | 2011-05-27 | 2011-05-27 | 1 | 2011-10-21 | View Edit Delete | ||||||||||||
| 605578 | 67164 | PROPOFOL LIPOVEN FRESENIUS 10 mg/ml EMULSION INYECTABLE Y PARA PERFUSION | PROPOFOL LIPOVEN FRESENIUS 10 mg/ml EMULSION INYECTABLE Y PARA PERFUSION , 10 viales de 50 ml | 10 mg/ml inyectable 50 ml | 45 | 10 | 34 | 10 viales de 50 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67164/67164_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67164/67164_p.pdf | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1097 | FRESENIUS KABI ESPAÑA, S.A.U. | 2005-11-02 | 1 | 1 | 1 | 2005-11-02 | 2011-09-13 | 1 | 2014-04-17 | View Edit Delete | ||||||||||||
| 605579 | 67164 | PROPOFOL LIPOVEN FRESENIUS 10 mg/ml EMULSION INYECTABLE Y PARA PERFUSION | PROPOFOL LIPOVEN FRESENIUS 10 mg/ml EMULSION INYECTABLE Y PARA PERFUSION , 10 viales de 100 ml | 10 mg/ml inyectable 100 ml | 45 | 10 | 34 | 10 viales de 100 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67164/67164_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67164/67164_p.pdf | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1097 | FRESENIUS KABI ESPAÑA, S.A.U. | 2005-11-02 | 1 | 1 | 1 | 2005-11-02 | 2011-09-13 | 1 | 2014-04-17 | View Edit Delete | ||||||||||||
| 605677 | 74477 | PARACETAMOL KABI 10 mg/ml SOLUCION PARA PERFUSION EFG | PARACETAMOL KABI 10 mg/ml SOLUCION PARA PERFUSION EFG , 10 viales de 100 ml | 1.000 mg | 45 | 10 | 34 | 10 viales de 100 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74477/74477_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74477/74477_p.pdf | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2011-12-12 | 1 | 1 | 1 | 2011-12-12 | 2011-12-12 | 1 | 2012-04-16 | View Edit Delete | ||||||||||||
| 605996 | 72750 | CEFEPIMA KABI 1G POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG | CEFEPIMA KABI 1G POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG , 10 viales de 20 ml (Tipo II o III) | 1.000 mg | 45 | 10 | 34 | 10 viales de 20 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72750/72750_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72750/72750_p.pdf | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2012-11-22 | 1 | 1 | 1 | 2012-11-22 | 2012-11-22 | 0 | 2013-03-04 | View Edit Delete | ||||||||||||
| 605997 | 72751 | CEFEPIMA KABI 2G POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG | CEFEPIMA KABI 2G POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG , 10 viales de 20 ml (Tipo II o III) | 2.000 mg | 45 | 10 | 34 | 10 viales de 20 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72751/72751_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72751/72751_p.pdf | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2012-11-21 | 1 | 1 | 1 | 2012-11-21 | 2012-11-21 | 0 | 2013-03-04 | View Edit Delete | ||||||||||||
| 600299 | 67021 | CEFAZOLINA SALA 2 G POLVO PARA SOLUCION INYECTABLE EFG | CEFAZOLINA SALA 2 G POLVO PARA SOLUCION INYECTABLE EFG, 50 viales | 2.000 mg | 45 | 50 | 34 | 50 viales | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67021/67021_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67021/67021_p.pdf | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 2367 | LABORATORIO REIG JOFRE, S.A. | 2005-09-05 | 1 | 1 | 1 | 2005-09-05 | 2005-09-05 | 0 | 2012-01-02 | View Edit Delete | ||||||||||||
| 600300 | 67022 | CEFAZOLINA SALA 1 G POLVO PARA SOLUCION INYECTABLE EFG | CEFAZOLINA SALA 1 G POLVO PARA SOLUCION INYECTABLE EFG, 100 viales | 1.000 mg | 45 | 100 | 34 | 100 viales | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67022/67022_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67022/67022_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 2367 | LABORATORIO REIG JOFRE, S.A. | 2005-09-06 | 1 | 1 | 1 | 2005-09-06 | 2005-09-06 | 0 | 2012-01-02 | View Edit Delete | ||||||||||||
| 600633 | 67871 | CEFTAZIDIMA SALA 1.000 mg POLVO PARA SOLUCION PARA PERFUSION EFG | CEFTAZIDIMA SALA 1.000 mg POLVO PARA SOLUCION PARA PERFUSION EFG , 50 viales | 1.000 mg | 45 | 50 | 34 | 50 viales | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67871/67871_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67871/67871_p.pdf | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 2367 | LABORATORIO REIG JOFRE, S.A. | 2006-06-13 | 1 | 1 | 1 | 2006-06-13 | 2006-06-13 | 1 | 2012-01-02 | View Edit Delete |
Page 19 of 1034, showing 20 records out of 20674 total, starting on record 361, ending on 380